locoregional recurrence

Related by string. * : locoregional disease . locoregional control . locoregional / Recurrences . recurrences . Recurrence : Oncotype DX Recurrence Score . biochemical recurrence . CDI recurrence . prevent recurrence . adenoma recurrence . breast cancer recurrence . tumor recurrence . Breast Cancer Recurrence . breast cancer recurrences . recurrence . Recurrence Score . prevent recurrences * *

Related by context. Frequent words. (Click for all words.) 73 distant metastasis 72 neoadjuvant therapy 72 distant metastases 72 lymph node metastases 71 neoadjuvant chemotherapy 70 EBRT 69 lymph node involvement 69 neoadjuvant 69 chemoradiotherapy 69 liver transplant recipients 69 breast carcinoma 69 thromboembolic events 69 tumor recurrence 68 chemoradiation 68 tumor resection 68 cystectomy 67 neoplasms 67 confidence interval #.#-#.# 67 liver metastases 67 prognostic factor 67 serum PSA 67 adjuvant therapy 67 statistically significant p = 66 mycophenolate mofetil 66 vertebral fracture 66 median PFS 66 univariate analysis 66 neoplasm 66 febrile neutropenia 65 P = .# 65 malignant pleural mesothelioma 65 PCa 65 % CI #.#-#.# [007] 65 Irinotecan 65 androgen deprivation 65 resected 65 brain metastases 65 fluorouracil 65 Median survival 65 goserelin 65 xenograft models 65 adjuvant chemotherapy 65 malignant lesions 65 XELOX 65 HER2 negative 65 subgroup analyzes 65 tumor shrinkage 65 thromboembolism 64 allogeneic stem cell 64 patients evaluable 64 plus dexamethasone 64 tumor lysis syndrome 64 chlorambucil 64 pheochromocytoma 64 cytogenetic response 64 mitoxantrone 64 elevated CRP 64 resections 64 reoperation 64 endometrial cancers 64 Erlotinib 64 CMV disease 64 FOLFIRI 64 histologic 64 HER2 positive metastatic breast 64 multivariate analyzes 63 TACE 63 mediastinal 63 fibrinolysis 63 heavily pretreated 63 RECIST criteria 63 systemic embolism 63 serum calcium 63 infarct size 63 bone metastasis 63 CaP 63 ovarian breast 63 adenoma 63 KRAS mutations 63 Amrubicin 63 immunohistochemical 63 virologic response 63 estrogen receptor ER 63 epirubicin 63 achieved statistical significance 63 TURP 63 Secondary endpoints included 63 HSCT 63 Fludara 63 dacarbazine 63 cardiac dysfunction 63 temsirolimus 63 histologically 63 nab paclitaxel 63 complete cytogenetic 62 adecatumumab 62 metastases 62 lobectomy 62 complete remissions 62 adenocarcinomas 62 myocardial infarctions

Back to home page